DOI: 10.1128/AAC.01734-18
Article Information
PubMed
Published By
History
- Received August 17, 2018
- Returned for modification September 12, 2018
- Accepted October 18, 2018
- Published online December 21, 2018.
Copyright & Usage
Copyright © 2018 Lam et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (October 29, 2018).
- You are viewing the most recent version of this article.
Author Information
- Angela M. Lama,
- Christine Espiritua,
- Robert Vogela,
- Suping Rena,
- Vincent Laua,
- Mollie Kellya,
- Scott D. Kuduka,
- George D. Hartmana,
- Osvaldo A. Floresa and
- Klaus Klumppa
- Address correspondence to Angela M. Lam, alam16{at}its.jnj.com.
Citation Lam AM, Espiritu C, Vogel R, Ren S, Lau V, Kelly M, Kuduk SD, Hartman GD, Flores OA, Klumpp K. 2019. Preclinical characterization of NVR 3-778, a first-in-class capsid assembly modulator against hepatitis B virus. Antimicrob Agents Chemother 63:e01734-18. https://doi.org/10.1128/AAC.01734-18.
